EBSのPER（株価収益率）は？

EMERGENT BIOSOLUTIONS INC（EBS）は現在PER 6.50倍で取引されています。

EBSのROE（自己資本利益率）は？

EMERGENT BIOSOLUTIONS INCのROEは-1.64%です。

EBSの配当利回りは？

EMERGENT BIOSOLUTIONS INCの配当利回りは0.00%です。

EBSの品質スコア（Quality Score）は？

当社のAIはEBSの総合財務品質を100点中38点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。

EBSは今が買い時ですか？

当社AIのタイミングスコアは100点中26点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。

EBSはどのセクターに属しますか？

EMERGENT BIOSOLUTIONS INCはHealthcare >> Drug Manufacturers - Specialty & Genericセクターに分類されます（NYSE市場）

EBS (NYSE) 株価分析 | EMERGENT BIOSOLUTIONS INC

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-03-31)

EBS AI Analysis Summary

Our AI summary for EBS: EMERGENT BIOSOLUTIONS INC (NYSE), Healthcare >> Drug Manufacturers - Specialty & Generic sector. The stock currently trades at a P/E of 6.50, ROE of -1.64%, a dividend yield of 0.00%. Its financial Quality Score stands at 38/100 — fundamentals below the market average. The AI Timing Score is 26/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

EBS

EMERGENT BIOSOLUTIONS INC

USD 7.22

-0.04 (-0.55%) Day Change

Watchlist Portfolio Compare Chart

6.50

P/E

1.10

D/E

-1.6%

ROE

-0.7%

ROA

0.00%

Div Yield

0.39

PEG

EMERGENT BIOSOLUTIONS INC
TYPE: STOCK
MARKET: NYSE

Compare Watchlist Myport

USD 7.22 Price -0.04 (-0.55%) Day Change	NEWS SCORE: 94

EBS, ファンダメンタルスコアはnot good ( ファンダメンタル = 38) そしてテクニカルスコアは ...(Sign In to See)...

Loading chart...

38 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROEが低い
ROAが低い
平均ROEが低い
ROEが昨年度比で低い
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not quite good , financial health is not good , and ability to make profit is not quite good , ...

Deepscope 分析

57%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	94
Magic Formula Rank by ROA	690
Magic Formula Rank by ROE	690
Magic Formula Rank by ROIC	268
Price	7.22
PBV / Sector	0.72 / 3.22 GREAT
Earning Per Share	-0.16

PE / Sector	6.50 / 29.79 GREAT
PEG or PE/Growth / Sector	0.39 / 0.13 GOOD
Average 1M Daily Value	4.58 M GREAT
Average 1W Daily Value	3.47 M GREAT

Timing Factors

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ポイントになる統計

56%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-1.27 / 15.21
NPM Average (%) / Sector	-20.77 / -10.83
NPM Change Average (%) / Sector	-12.19 / 117.42
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-0.65 / 8.15
ROA Average (%) / Sector	-11.75 / 2.87
ROA Change Average (%) / Sector	52.91 / 112.70 GREAT
ROE (%) / Sector	-1.64 / -1.02
ROE Average (%) / Sector	-32.69 / 8.35
ROE Change Average (%) / Sector	90.00 / 385.91 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

配当

Dividend (%) / Sector	N/A / 0.51
Dividend Average (%) / Sector	N/A / 3.06
Dividend Change Average (%) / Sector	N/A / 13.64

登録情報

Analyze Date	2026-08-01 07:59:45
Symbol	EBS
Name	EMERGENT BIOSOLUTIONS INC
Sector	Healthcare >> Drug Manufacturers - Specialty & Generic
Market	NYSE
Listed Shares	51.60 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	377.17 / 10,754.62

ニュース

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 300 Professional Drive, Gaithersburg, MD, United States, 20879

Phone: 240 631 3200

Website: https://www.emergentbiosolutions.com

Employees: 900

Sector: Healthcare >> Drug Manufacturers - Specialty & Generic

Description: Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States, Canada, and internationally. It operates through Commercial Products, MCM Products, and All Other Revenues segments. The company offers ACAM2000, a smallpox and mpox vaccine; Anthrax Immune Globulin Intravenous (ANTHRASIL), a polyclonal antibody therapeutic for the treatment of inhalational anthrax; Botulism Antitoxin Heptavalent (BAT), an equine plasma antitoxin for the treatment of symptomatic botulism; BioThrax, an anthrax vaccine; CYFENDUS, a vaccine for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis; Ebanga, a monoclonal antibody for the treatment of infection caused by Orthoebolavirus zairense; Raxibacumab injection, a monoclonal antibody therapeutic for the treatment and prophylaxis of inhalational anthrax due to Bacillus anthracis; TEMBEXA, an oral antiviral for the treatment of smallpox disease caused by variola virus in adult and pediatric patients; and CNJ-016, a polyclonal antibody therapeutic to address complications from smallpox vaccination. It also provides NARCAN and KLOXXADO nasal sprays for the emergency treatment of known or suspected opioid overdose. In addition, the company offers contract development and manufacturing services comprising drug substance and product manufacturing, and packaging, as well as technology transfer, process, analytical development, and suite reservation services. Emergent BioSolutions Inc. was incorporated in 1998 and is headquartered in Gaithersburg, Maryland.